We are an international
independent scientific network

devoted to advancing research on optimising the prevention,
diagnosis and treatment of infectious diseases in children globally

Linking experts from
around the world

in an independent global collaboration that seeks to standardize
best practices across disease areas and populations

Sharing values and goals

such as flexibility, commitment and transparency

Researching the right drug
and the right dose

to generate the scientific data necessary to market drugs
at doses that are safe and effective for children

Understanding the
immune response

so as to harness the body's response
to HIV and antiretrovirals

Fighting
antimicrobial resistance

to ensure effective treatments are available
for common infections for generations to come

Paving the way for women,
children and their families

to make powerful informed decisions about their health
and healthcare and improve the quality of their lives

The winners of Penta’s Brighter Future Award have been announced, and their exceptional work is now available for everyone to witness!

Dive into their captivating videos to gain insights into their work and passion to improve health outcomes for children and women.

Get to know us

Penta is an international independent scientific network dedicated to child health. Our work is the result of a passionate collaboration between healthcare professionals and researchers in more than 110 centres across 31 countries around the world.

Through our studies and partnerships, we develop and deliver world-class research and training in paediatric infectious diseases to improve the lives of women and children, wherever they live.

Are you interested joining the Penta ID Network? Complete this form to apply.

Current Penta studies around the World

Always expanding

Penta continues to grow, bringing together healthcare professionals, researchers and scientists worldwide to address a wide range of healthcare issues.

Members

Countries

Years of activity

Ongoing studies and projects

Latest News

AMR, bacterial transmission and infections in the neonatal unit: 5 questions for the NeoIPC Microbiology Team

17 Oct, 2024

The Laboratory of Medical Microbiology at the University of Antwerp, Belgium, plays a crucial role in the NeoIPC project, acting as the central microbiology laboratory for its various studies. Recently, we had…

European project ORCHESTRA ends, yielding key insights into COVID-19 and Long-COVID

08 Oct, 2024

The ORCHESTRA project, “Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic”, has officially concluded. This European research initiative brought together scientists from 37 different partner institutions from…

Second edition of our “PentaTr@ining 2024: Fungal Infections in Paediatrics course” launches

27 Sep, 2024

On 16th September, 2024 we kicked off the second edition of our online course, “Fungal Infections in Paediatrics” on our PentaTr@ining platform, with more than 200 delegates logging in from across the world. The innovative programme is run on our virtual learning environment, providing…

Advancing health equity through inclusive clinical trials

24 Sep, 2024

In healthcare, inclusivity is not just a moral imperative, it is also a strategic necessity for achieving widespread immunity to infections and diseases, like COVID-19, and advancing public health outcomes.…

Improving the treatment of neonatal sepsis in resource-limited settings: the SNIP-AFRICA project

13 Sep, 2024

Every year, on September 13th, we observe World Sepsis Day, an important date in the calendar to raise awareness about sepsis – a life-threatening condition that occurs when the body’s response…